Literature DB >> 16253648

The C161-->T polymorphism in peroxisome proliferator-activated receptor gamma, but not P12A, is associated with insulin resistance in Hispanic and non-Hispanic white women: evidence for another functional variant in peroxisome proliferator-activated receptor gamma.

Susan P Moffett1, Eleanor Feingold, M Michael Barmada, Coleen M Damcott, Julie A Marshall, Richard F Hamman, Robert E Ferrell.   

Abstract

The P12A variant in the peroxisome proliferator-activated receptor gamma (PPARgamma) gene has been intensely studied for association with obesity-related or type-2 diabetes-related traits; however, the results have been somewhat inconsistent in different populations. We genotyped a large cohort of Hispanic and non-Hispanic white individuals from the San Luis Valley Diabetes Study for P12A and another common variant, C161-->T, in the PPARgamma gene to determine if these sites were associated with fasting glucose, insulin, free fatty acid levels, insulin sensitivity, or body fat. There were no statistically significant frequency differences at these two sites between Hispanic and non-Hispanic individuals. No significant association with the metabolic phenotypes was observed for either of the polymorphisms in men; however, in women, significant associations were shown between the C161-->T variant and fasting insulin (P=.008) and the homeostasis model assessment of insulin resistance (HOMA IR; P=.007). After adjusting for age, smoking, fat mass, and skin reflectance, linear regression showed that C161-->T explained 1.5% of the variation in both fasting insulin (P=.031) and HOMA IR (P=.028) whereas P12A contributed only 0.04% (fasting insulin, P=.268) and 0.02% (HOMA IR, P=.418) to the total trait variation. In the San Luis Valley Diabetes Study female patients, C161-->T appears to be a better predictor of fasting insulin levels and insulin resistance than P12A although the effect of this variant is small. These results support the hypothesis that C161-->T is in linkage disequilibrium with unidentified functional variation in PPARgamma or in a linked gene. This could explain some of the inconsistencies in the P12A association studies as the allele frequency and level of linkage disequilibrium of another functional polymorphism in the region could vary in different populations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16253648     DOI: 10.1016/j.metabol.2005.05.025

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  13 in total

1.  Combined effects of the C161T and Pro12Ala PPARγ2 gene variants with insulin resistance on metabolic syndrome: a case-control study of a central Tunisian population.

Authors:  Sarraj Mohamed Youssef; Najah Mohamed; Slimani Afef; Ben Hamda Khaldoun; Neffati Fadoua; Najjar Mohamed Fadhel; Slimene Mohamed Naceur
Journal:  J Mol Neurosci       Date:  2013-11-19       Impact factor: 3.444

Review 2.  Dietary fat, genes and insulin sensitivity.

Authors:  José López-Miranda; Pablo Pérez-Martínez; Carmen Marin; Francisco Fuentes; Javier Delgado; Francisco Pérez-Jiménez
Journal:  J Mol Med (Berl)       Date:  2006-12-15       Impact factor: 4.599

3.  Effect of the PPARγ C161T gene variant on serum lipids in ischemic stroke patients with and without type 2 diabetes mellitus.

Authors:  Khouloud Chehaibi; Samir Nouira; Kacem Mahdouani; Sonia Hamdi; Mustapha Rouis; Mohamed Naceur Slimane
Journal:  J Mol Neurosci       Date:  2014-05-21       Impact factor: 3.444

4.  Association between C1431T polymorphism in peroxisome proliferator-activated receptor-γ gene and coronary artery disease in Chinese Han population.

Authors:  Xiang Zhou; Jianchang Chen; Weiting Xu
Journal:  Mol Biol Rep       Date:  2011-06-04       Impact factor: 2.316

5.  PPARgamma gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus.

Authors:  Jing Wan; Shixi Xiong; Shengping Chao; Jianming Xiao; Yexin Ma; Jinghua Wang; Sabita Roy
Journal:  Cardiovasc Diabetol       Date:  2010-03-24       Impact factor: 9.951

6.  The C161T polymorphism in the peroxisome proliferator-activated receptor gamma gene (PPARγ) is associated with risk of coronary artery disease: a meta-analysis.

Authors:  Zhijun Wu; Yuqing Lou; Wei Jin; Yan Liu; Lin Lu; Guoping Lu
Journal:  Mol Biol Rep       Date:  2012-12-25       Impact factor: 2.316

7.  Effects of PPARγ and RBP4 gene variants on metabolic syndrome in HIV-infected patients with anti-retroviral therapy.

Authors:  Yuan-Pin Hung; Nan-Yao Lee; Sheng-Hsiang Lin; Ho-Ching Chang; Chi-Jung Wu; Chia-Ming Chang; Po-Lin Chen; Hsiao-Ju Lin; Yi-Hui Wu; Pei-Jane Tsai; Yau-Sheng Tsai; Wen-Chien Ko
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

8.  PPARγ2 polymorphism and human health.

Authors:  Weimin He
Journal:  PPAR Res       Date:  2009-04-16       Impact factor: 4.964

9.  The Genetics of PPARG and the Skeleton.

Authors:  Cheryl Ackert-Bicknell; Clifford Rosen
Journal:  PPAR Res       Date:  2006       Impact factor: 4.964

10.  Distribution and genotype frequency of the C1431T and pro12ala polymorphisms of the peroxisome proliferator activator receptor gamma gene in an Iranian population.

Authors:  Hassan Rooki; Monir-Sadat Haerian; Pedram Azimzadeh; Mahmoud Ebrahimi; Reza Mirhafez; Gordon Ferns; Majid Ghayour-Mobarhan; Mohammad-Reza Zali
Journal:  Indian J Hum Genet       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.